Favorable outcome of patients with lung adenocarcinoma harboring POLE mutations and expressing high PD-L1

Mutations in polymerase ε (POLE) confer favorable prognosis and outcomes in various cancer types, but their role in non-small cell lung cancer (NSCLC) is unknown. Utilizing the data of 513 patients with adenocarcinoma (LUAD) and 497 patients with squamous cell carcinoma (LUSC) from The Cancer Genome...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Liang, Ruiz, Jimmy, O’Neill, Stacey S., Grant, Stefan C., Petty, W. Jeffrey, Yang, Meng, Chen, Kexin, Topaloglu, Umit, Pasche, Boris, Zhang, Wei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5897927/
https://www.ncbi.nlm.nih.gov/pubmed/29650000
http://dx.doi.org/10.1186/s12943-018-0832-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5897927/
https://www.ncbi.nlm.nih.gov/pubmed/29650000
http://dx.doi.org/10.1186/s12943-018-0832-y

Ejemplares similares